Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 18 June 2027
- Last conf. stmt
- 4 June 2026
Als Iii Member Co Limited
- Incorporated
- 5 June 2018 (8 years)
- Industry
- Fund management activities (66300)
- Owned by
- Accounts type
- Micro entity
- Region
- Greater London
- Address
- 27 Fitzroy SquareLondonW1T 6ES
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 5 June 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Liability Partnership
Reg. no. Oc347034
Other holdings 7
Companies where Als Iii Member Co Limited is registered as a person with significant control
Holds 25–50% of voting rights
Active
Part right to 75–100% of surplus assets
Active
Holds 25–50% of voting rights
Active
Holds 25–50% of voting rights
Active
Holds 25–50% of voting rights
Active
Holds 25–50% of voting rights
Active
Holds 25–50% of voting rights
Active
Group structure 17 companies
Ownership group derived from the Companies House PSC register
Advent Life Sciences GP LLP Right to 75–100% of surplus assets
Advent LS Services Limited Owns 75–100% of shares
Als Growth GP LLP Right to 75–100% of surplus assets
Als Iii Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Als Carry LP Has significant influence or control
Als Iii Carry and Co-Invest LP Part right to 50–75% of surplus assets (as a firm)
Als Iii GP LLP Holds 75–100% of voting rights
Als Iii Member Co Limited This company Owns 75–100% of shares
Als IV Carry and Co-Invest LP Part right to 75–100% of surplus assets
Als IV Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest LP Has significant influence or control
Cenentry Biosciences Limited Owns 25–50% of shares
Fiera Oncology Limited Owns 25–50% of shares
Pheno Therapeutics Limited Owns 50–75% of shares (as a firm)
Ventus Medical Limited Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £11
- Debt Ratio
- 31%
- Current Ratio
- 2.2x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|
| Fixed Assets | £5 | £5 | £3 | £3 | £3 |
| Current Assets | £11 | £11 | £11 | £11 | £11 |
| Creditors (< 1 year) | £5 | £5 | £3 | ||
| Creditors (> 1 year) | £0 | £0 | £3 | ||
| Net Current Assets | £6 | £6 | £8 | £11 | £11 |
| Net Assets | £11 | £11 | £11 | £11 | £11 |
| Shareholder Funds | £11 | £11 | £11 | £11 | £11 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 June 2026 | Confirmation statement with updates | 4 June 2026 | ||
| 24 September 2025 | Micro company accounts | 31 December 2024 | ||
| 6 June 2025 | Confirmation statement with updates | 4 June 2025 | ||
| 27 September 2024 | Micro company accounts | 31 December 2023 | ||
| 4 June 2024 | Confirmation statement with no updates | 4 June 2024 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →